Table 4.
P. falciparumCSP positivity ofAnopheles gambiae s.s.identified to both molecular and chromosomal form. Status as M molecular form and Mopti chromosomal form was significantly associated with CSP positivity in October 2009 (P = 0.001)
|
No. CSP Pos. / No. Screened (% Pos.) | ||||
|---|---|---|---|---|
| Chromosomal Form |
Molecular Form |
Total | ||
| M | S | M/S | ||
|
Kela | ||||
|
Bamako |
0/0 (0%) |
11/117 (9.4%) |
0/1 (0%) |
11/118 (9.3%) |
|
Savanna |
2/6 (33.3%) |
5/10 (50.0%) |
0/0 (0%) |
7/16 (43.8%) |
|
Mopti |
6/38 (15.8%) |
0/1 (0.0%) |
0/0 (0%) |
6/39 (15.4%) |
|
Total |
8/44 (18.2%) |
16/128 (12.5%) |
0/1 (0%) |
24/173 (13.9%) |
|
Sidarebougou | ||||
|
Bamako |
0/0 (0.0%) |
0/2 (0%) |
0/0 (0.0%) |
0/2 (0.0%) |
|
Savanna |
1/13 (7.7%) |
15/108 (13.9%) |
1/4 (25.0%) |
17/125 (13.6%) |
|
Mopti |
5/19 (26.3%) |
0/1 (0%) |
0/0 (0.0%) |
5/20 (25.0%) |
|
Total |
6/32 (18.8%) |
15/111 (13.5%) |
1/4 (25.0%) |
22/147 (15.0%) |
|
Mali | ||||
|
Bamako |
0/0 (0.0%) |
11/119 (9.2%) |
0/1 (0.0%) |
11/120 (9.2%) |
|
Savanna |
3/19 (15.8%) |
20/118 (16.9%) |
1/4 (25.0%) |
24/141 (17.0%) |
|
Mopti |
11/57 (19.3%) |
0/2 (0.0%) |
0/0 (0.0%) |
11/59 (18.6%) |
| Total | 14/76 (18.4%) | 31/239 (13.0%) | 1/5 (20.0%) | 46/320 (14.4%) |